Cargando…
A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma
Rare or orphan diseases affect only small populations, thereby limiting the economic incentive for the drug development process, often resulting in a lack of progress towards treatment. Drug repositioning is a promising approach in these cases, due to its low cost. In this approach, one attempts to...
Autores principales: | Lotfi Shahreza, Maryam, Ghadiri, Nasser, Green, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264316/ https://www.ncbi.nlm.nih.gov/pubmed/32483162 http://dx.doi.org/10.1038/s41598-020-65658-x |
Ejemplares similares
-
Systems Biology–Derived Genetic Signatures of Mastitis in Dairy Cattle: A New Avenue for Drug Repurposing
por: Sharifi, Somayeh, et al.
Publicado: (2021) -
Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis
por: Villalba Silva, Gerda Cristal, et al.
Publicado: (2022) -
Large-scale computational drug repositioning to find treatments for rare diseases
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2018) -
Repositioning Drugs for Rare Diseases Based on Biological Features and Computational Approaches
por: Otero-Carrasco, Belén, et al.
Publicado: (2022) -
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)